Ethyl Loflazepate


Indications and Reactions:

Role Indications Reactions
Secondary
Insomnia 23.9%
Drug Use For Unknown Indication 14.4%
Product Used For Unknown Indication 12.8%
Dysthymic Disorder 6.4%
Overdose 5.3%
Alcoholic Psychosis 4.8%
Cardiac Disorder 4.8%
Anger 4.0%
Restlessness 4.0%
Cough 2.7%
Depression 2.7%
Productive Cough 2.7%
Intentional Overdose 2.1%
Non-obstructive Cardiomyopathy 2.1%
Hypertension 1.6%
Oropharyngeal Pain 1.6%
Epilepsy 1.1%
Gastritis 1.1%
Hypertrophic Cardiomyopathy 1.1%
Mycobacterium Avium Complex Infection 1.1%
Oedema 19.0%
Pulmonary Embolism 12.1%
Pseudomembranous Colitis 10.3%
Ventricular Tachycardia 8.6%
Galactorrhoea 6.9%
Pyrexia 5.2%
Restlessness 5.2%
Anaphylactic Shock 3.4%
Myoclonus 3.4%
Psychiatric Symptom 3.4%
Tricuspid Valve Incompetence 3.4%
Vomiting Neonatal 3.4%
Weight Increased 3.4%
Delirium 1.7%
Intentional Drug Misuse 1.7%
Intentional Overdose 1.7%
Liver Disorder 1.7%
Loss Of Consciousness 1.7%
Overdose 1.7%
Parkinsonism 1.7%
Concomitant
Depression 24.1%
Crohn's Disease 10.8%
Drug Use For Unknown Indication 10.0%
Product Used For Unknown Indication 7.0%
Insomnia 5.7%
Anxiety Disorder 5.4%
Aplastic Anaemia 3.8%
Panic Disorder 3.8%
Non-small Cell Lung Cancer 3.3%
Premenstrual Syndrome 3.3%
Prophylaxis 3.3%
Angina Pectoris 2.7%
Back Pain 2.4%
Hypertension 2.4%
Social Phobia 2.4%
Anxiety 2.2%
Constipation 1.9%
Osteoporosis 1.9%
Rheumatoid Arthritis 1.9%
Breast Cancer 1.6%
Completed Suicide 8.8%
Suicide Attempt 8.8%
Crohn's Disease 7.0%
Lumbar Spinal Stenosis 7.0%
Vomiting 7.0%
Weight Decreased 7.0%
Stevens-johnson Syndrome 5.3%
Suicidal Ideation 5.3%
Tremor 5.3%
Antibiotic Resistant Staphylococcus Test Positive 3.5%
Carpal Tunnel Syndrome 3.5%
Cerebral Infarction 3.5%
Extrapyramidal Disorder 3.5%
Glucose Tolerance Impaired 3.5%
Hypoacusis 3.5%
Hypoparathyroidism 3.5%
Intentional Overdose 3.5%
Jaundice 3.5%
Liver Disorder 3.5%
Maternal Drugs Affecting Foetus 3.5%

Drug Data